Todd Brady
Directeur/Bestuurslid bij CONTINEUM THERAPEUTICS, INC.
Profiel
Todd R.
Brady is currently a Director at Vero Biotech LLC, Brace Pharmaceuticals, Inc., Vero Biotech, Inc., and Contineum Therapeutics, Inc. He previously held positions as a Director at Therabron Therapeutics, Inc., Avidity Biosciences, Inc., Tyrogenex, Inc., Cocrystal Pharma, Inc., and Interward Asset Management Ltd.
Mr. Brady completed his undergraduate degree at the University of Western Ontario and earned an MBA from The Schulich School of Business in 2007.
Actieve functies van Todd Brady
| Bedrijven | Functie | Begin |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-11-2019 |
Vero Biotech LLC
 Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Directeur/Bestuurslid | - |
Brace Pharmaceuticals, Inc.
 Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals, Inc (Brace Pharmaceuticals) is a venture capital firm founded in 2013. The firm is headquartered in Atlanta. | Financieel Directeur/CFO | 01-01-2014 |
| Vero Biotech, Inc. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Todd Brady
| Bedrijven | Functie | Einde |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Directeur/Bestuurslid | 11-01-2021 |
| COCRYSTAL PHARMA, INC. | Directeur/Bestuurslid | 10-03-2020 |
Interward Asset Management Ltd.
 Interward Asset Management Ltd. Investment ManagersFinance Interward Asset Management, Ltd. (IAML) is a Canadian multi-family office headquartered in Toronto, Ontario. The firm was founded by Kim Ward in 1990. IAML serves a discrete number of high-net-worth clients focused on private and public equities. | Analyst-Equity | 31-12-2008 |
Therabron Therapeutics, Inc.
 Therabron Therapeutics, Inc. BiotechnologyHealth Technology Therabron Therapeutics, Inc. provides biotechnology services. It is focused on the advancement of respiratory therapeutics with disease-modifying potential. The company was founded by Aprile Pilon in 2007 and is headquartered in Rockville, MD. | Directeur/Bestuurslid | - |
Tyrogenex, Inc.
 Tyrogenex, Inc. Pharmaceuticals: MajorHealth Technology Tyrogenex, Inc. operates as a biopharmaceutical company which develops dual vascular endothelial growth factor receptor and platelet-derived growth factor receptor inhibitors for wet age-related macular degeneration and solid tumors. Its compound targets the basic mechanisms of neovascular eye diseases, including angiogenesis, fibrosis and inflammation. The company was founded by Chris Liang, Teri Ardleigh Swift, and Sheridan G. Snyder and is headquartered in Rockville, MD. | Directeur/Bestuurslid | - |
Opleiding van Todd Brady
| University of Western Ontario | Undergraduate Degree |
| The Schulich School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| AVIDITY BIOSCIENCES, INC. | Health Technology |
| COCRYSTAL PHARMA, INC. | Health Technology |
| CONTINEUM THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
Interward Asset Management Ltd.
Interward Asset Management Ltd. Investment ManagersFinance Interward Asset Management, Ltd. (IAML) is a Canadian multi-family office headquartered in Toronto, Ontario. The firm was founded by Kim Ward in 1990. IAML serves a discrete number of high-net-worth clients focused on private and public equities. | Finance |
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Health Technology |
Tyrogenex, Inc.
Tyrogenex, Inc. Pharmaceuticals: MajorHealth Technology Tyrogenex, Inc. operates as a biopharmaceutical company which develops dual vascular endothelial growth factor receptor and platelet-derived growth factor receptor inhibitors for wet age-related macular degeneration and solid tumors. Its compound targets the basic mechanisms of neovascular eye diseases, including angiogenesis, fibrosis and inflammation. The company was founded by Chris Liang, Teri Ardleigh Swift, and Sheridan G. Snyder and is headquartered in Rockville, MD. | Health Technology |
Therabron Therapeutics, Inc.
Therabron Therapeutics, Inc. BiotechnologyHealth Technology Therabron Therapeutics, Inc. provides biotechnology services. It is focused on the advancement of respiratory therapeutics with disease-modifying potential. The company was founded by Aprile Pilon in 2007 and is headquartered in Rockville, MD. | Health Technology |
Brace Pharmaceuticals, Inc.
Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals, Inc (Brace Pharmaceuticals) is a venture capital firm founded in 2013. The firm is headquartered in Atlanta. | Finance |
| Vero Biotech, Inc. |
